High Quality Heparin sodium CAS NO.9041-08-1
- FOB Price: USD: 1.00-1.00 /Gram Get Latest Price
- Min.Order: 1 Gram
- Payment Terms: L/C,D/A,D/P,T/T,
- Available Specifications:
1(1-2)Gram
- Product Details
Keywords
- 9041-08-1
- Heparin sodium
- Heparin sodium Price
Quick Details
- ProName: High Quality Heparin sodium
- CasNo: 9041-08-1
- Molecular Formula: (C12H16NS2Na3)20
- Appearance: White powder
- Application: pharmaceutical intermediates
- DeliveryTime: Qingdao Port
- PackAge: 1kg or 25Kg drum
- Port: QIngdao Port
- ProductionCapacity: 3000 Metric Ton/Year
- Purity: 98% HPLC
- Storage: Store in dry, dark and ventilated plac...
- Transportation: By air or by sea. Prompt delivery
- LimitNum: 1 Gram
- Moisture Content: See data sheet
- Samples: Available
Superiority
We promise our customer following items
1.Reasonable price:
2.Low moq:No worry about the low moq, our moq is 1 gram or lower.
3.Good and efficient service,Fast Delivery
4.Super-good quality
Details
Our advantages
High quality Heparin sodium
1.Competitive price
2.Fast Delivery Within 2 days
3.SGS , BV, GMP,ISO approve
Items |
Specifications |
Results |
Appearance |
White or milk whitecrystalline porder |
Qualified |
Identification |
Must pisitive |
Positive |
Odor |
Characteristicless |
Qualified |
Colour of solution |
Must qualified |
Qualified |
Related substances |
Must qualified |
Qualified |
Residual Solvent |
≤0.5% |
Qualified |
Acidity or alkalinity(PH) |
4.5-7.0 |
6.0 |
Absorptivity |
137 - 147 |
145 |
Optical rotation |
-1.27° -1.34° |
1.31° |
Heavy metals |
≤20ppm |
<20ppm |
Losson drying |
≤0.5% |
0.35% |
Sulphated ash |
≤0.1% |
0.05% |
Assay |
99.0-101.0% |
99.98% |
Conclusion: Conform with BP2007 Standard . |
2. Prevention of arterial and venous thrombosis and pulmonary embolism.
3. Treatment of arterial and venous thrombosis and pulmonary embolism, ischemic stroke, unstable angina (to alleviate the symptoms, prevention of myocardial infarction), acute myocardial infarction (prevention of early reinfarction and infarct extension, reduce mortality).
4. The artificial lung, peritoneal dialysis or hemodialysis as anticoagulants.
5. thrombolytic therapy as maintenance therapy.